Substrate-Controlled Regioselective Alkylation of 4-Hydroxycoumarin with Diazo Compounds through TfOH Catalysis

Abstract

Control of the regioselectivity of nucleophiles toward alkylating agents is a fundamental problem in heterocyclic chemistry. Substrate-controlled TfOH-catalyzed alkylation of 4-hydroxycoumarin with diazo compounds has been developed to provide rapid access to the C3- or O-alkylated 4-hydroxycoumarins with high efficiency. The regioselectivity can be determined by varying the electronic nature of the diazo substrates, especially those bearing a methylthio group.

Key words

4-hydroxycoumarin - diazo compounds - metal-free catalysis - alkylation - regioselectivity

Publikationsverlauf

Eingereicht: 06. Oktober 2023

Angenommen nach Revision: 07. November 2023

Artikel online veröffentlicht:
06. Dezember 2023

• References and Notes

• 1 Gomez-Outes A, Suarez-Gea ML, Calvo-Rojas G, Lecumberri R, Rocha E, Pozo-Hernandez C, Terleira-Fernandez AI, Vargas-Castrillon E. Curr. Drug Discovery Technol. 2012; 9: 83
• 2a Zhang J, Tan YL, Li GR, Chen LX, Nie MY, Wang ZH, Ji H. Molecules 2021; 26: 786
• 2b Stefanova TH, Nikolova NJ, Toshkova RA, Neychev HO. J. Exp. Ther. Oncol. 2007; 6: 107
• 3 Bizzarri BM, Botta L, Capecchi E, Celestino I, Checconi P, Palamara AT, Nencioni L, Saladino R. J. Nat. Prod. 2017; 80: 3248
• 4a Ong EB. B, Watanabe N, Saito A, Futamura Y, Abd El Galil KH, Koito A, Najimudin N, Osada H. J. Biol. Chem. 2011; 286: 14049
• 4b Wadhwa P, Jain P, Rudrawar S, Jadhav HR. A. Curr. Drug Discovery Technol. 2018; 15: 2
• 5a Pan L, Li X.-Z, Sun D.-A, Jin H, Guo H.-R, Qin B. Chin. Chem. Lett. 2016; 27: 375
• 5b Ellafi A, Farhat R, Snoussi M, Noumi E, Anouar E, Ben Ali R, El May MV, Sayadi S, Aouadi K, Kadri A, Ben Younes S. Int. J. Food Prop. 2023; 26: 1079
• 6a Bansal Y, Sethi P, Bansal G. Med. Chem. Res. 2013; 22: 3049
• 6b Mucha P, Skoczynska A, Malecka M, Hikisz P, Budzisz E. Molecules 2021; 26: 4886
• 7a Cheke RS, Patel HM, Patil VM, Ansari IA, Ambhore JP, Shinde SD, Kadri A, Snoussi M, Adnan M, Kharkar PS, Pasupuleti VR, Deshmukh PK. Antibiotics 2022; 11: 566
• 7b Mujahid M, Trendafilova N, Rosair G, Kavanagh K, Walsh M, Creaven BS, Georgieva I. Molecules 2023; 28: 4560
• 8a Xi G.-L, Liu Z.-Q. J. Agric. Food. Chem. 2015; 63: 3516
• 8b Chen C, Wang P, Zou LW, Yang L, Fan YM, Hu WZ, Ge GB. Chem. Res. Chin. Univ. 2017; 33: 194
• 9 Serra S, Chicca A, Delogu G, Vazquez-Rodriguez S, Santana L, Uriarte E, Casu L, Gertsch J. Bioorg. Med. Chem. Lett. 2012; 22: 5791
• 10a Andrianjafy TM, Ravaomanarivo LH, Ramanandraibe VV, Rakotondramanga MF, Mavingui P, Lemaire M. J. Chem. Ecol. 2018; 44: 299
• 10b Kischel J, Mertins K, Michalik D, Zapf A, Beller M. Adv. Synth. Catal. 2007; 349: 865
• 10c Montagut-Romans A, Boulven M, Lemaire M, Popowycz F. New J. Chem. 2014; 38: 1794
• 10d Rueping M, Nachtsheim BJ, Sugiono E. Synlett 2010; 1549
• 11a Su Q, Qian H, Li Z, Sun X, Wang Z. Asian J. Org. Chem. 2017; 6: 512
• 11b Kischel J, Michalik D, Zapf A, Beller M. Chem. Asian J. 2007; 2: 909
• 12a Koduri ND, Wang Z, Cannell G, Cooley K, Lemma TM, Miao K, Michael N, Frohock B, Castaneda M, Scott H, Albinescu D, Hussaini SR. J. Org. Chem. 2014; 79: 7405
• 12b Ren X, Liu N, Chandgude AL, Fasan R. Angew. Chem. Int. Ed. 2020; 59: 21634
• 12c Ren X, Chandgude AL, Fasan R. ACS Catal. 2020; 10: 2308
• 12d Wang R, He H, Yan Q, Wang W, Wang H, Chen F. J. Flow Chem. 2023; 13: 1
• 12e Dong K, Liu X.-S, Wei X, Zhao Y, Liu L. Green Synth. Catal. 2021; 2: 385
• 12f Shi T, Li X, Li Y, Fu X, Wu L, Wu D, Hu W. Green Synth. Catal. 2023; 4: 58
• 12g Tian X, Xu X, Jing T, Kang Z, Hu W. Green Synth. Catal. 2021; 2: 337
• 12h Wang H, Sun X, Hu M, Zhang X, Xie L, Gu S. Adv. Synth. Catal. 2020; 362: 3347
• 12i He H, Yan Z, Wang J, Yan Q, Wang W, Wang H, Chen F. New J. Chem. 2022; 46: 22513
• 13a Xiang YY, Wang C, Ding QP, Peng YY. Adv. Synth. Catal. 2019; 361: 919
• 13b Yan ZW, He HL, Yuan DB, Yan QJ, Wang W, Jiang HP, Wang HF, Chen FE. Chem. Commun. 2022; 59: 106
• 13c He H, Yan J, Jin J, Yan Z, Yan Q, Wang W, Jiang H, Wang H, Chen F. Chem. Commun. 2022; 58: 6429
• 14 General procedure for the synthesis of oxygen alkylation products: 4-Hydroxycoumarin derivatives 1 (0.10 mmol) and diazo compound 2 (0.3 mmol) in CH₂Cl₂ (1.0 mL) were added to a 10 mL reaction tube. A solution of CF₃SO₃H (0.02 mmol, 20 mol%) in CH₂Cl₂ (1 mL) was then introduced into the reaction mixture. The resulting mixture was continually stirred under a nitrogen atmosphere and heated to reflux for 3–6 h. The reaction solution was concentrated under reduced pressure. The crude product was purified by column chromatography on silica gel to afford pure products 3. Ethyl 2-((2-oxo-2H-chromen-4-yl)oxy)-2-phenylacetate (3a): Prepared by the general procedure. Compound 3a was isolated as a white solid; 84% yield (27.2 mg); eluent: petroleum ether/ethyl acetate = 15:1; mp 140–142 ℃. ¹H NMR (400 MHz, CDCl₃): δ = 7.92 (dd, J = 8.0, 1.6 Hz, 1 H), 7.55–7.46 (m, 3 H), 7.44–7.32 (m, 3 H), 7.29–7.20 (m, 2 H), 5.63 (s, 1 H), 5.54 (s, 1 H), 4.28–4.08 (m, 2 H), 1.18 (t, J = 7.2 Hz, 3 H). ¹³C NMR (100 MHz, CDCl₃): δ = 167.6, 164.1, 162.4, 153.4, 133.4, 132.7, 129.8, 129.2, 127.1, 124.1, 123.4, 116.8, 115.4, 92.2, 78.9, 62.4, 14.0. HRMS (ESI): m/z [M + H]⁺ calcd for C₁₉H₁₇O₅ ⁺: 325.1071; found: 325.1074. Ethyl 2-(4-chlorophenyl)-2-((2-oxo-2H-chromen-4-yl)oxy)acetate (3f): Prepared by the general procedure. Compound 3f was isolated as a white solid; 81% yield (29.0 mg); eluent: petroleum ether/ethyl acetate = 15:1; mp 102–104 ℃. ¹H NMR (400 MHz, CDCl₃): δ = 7.91–7.85 (m, 1 H), 7.53–7.44 (m, 3 H), 7.38–7.33 (m, 2 H), 7.27–7.21 (m, 2 H), 5.61 (s, 1 H), 5.51 (s, 1 H), 4.25–4.09 (m, 2 H), 1.17 (t, J = 7.2 Hz, 3 H). ¹³C NMR (100 MHz, CDCl₃): δ = 167.3, 163.9, 162.2, 153.4, 135.9, 132.8, 131.9, 129.4, 128.5, 124.2, 123.3, 116.8, 115.3, 92.3, 78.1, 62.6, 14.0. HRMS (ESI): m/z [M + H]⁺ calcd for C₁₉H₁₆ClO₅ ⁺: 359.0681; found: 359.0686.
• 15 General procedure for the synthesis of carbon alkylation products: 4-Hydroxycoumarin derivatives 1 (0.10 mmol) and diazo compound 4 (0.3 mmol) in CH₂Cl₂ (1.0 mL) were added to a 10 mL reaction tube. A solution of CF₃SO₃H (0.02 mmol, 20 mol%) in CH₂Cl₂ (1 mL) was then introduced into the reaction mixture. The resulting mixture was continually stirred under a nitrogen atmosphere and heated to reflux for 3–6 h. The reaction solution was concentrated under reduced pressure. The crude product was purified by column chromatography on silica gel to afford the pure products 5. Ethyl 2-(4-hydroxy-2-oxo-2H-chromen-3-yl)-2-(4-(methylthio)phenyl)acetate (5b): Prepared by the general procedure. Compound 5b was isolated as a yellow oil; 65% yield (24.1 mg); eluent: petroleum ether/ethyl acetate = 15:1. ¹H NMR (400 MHz, CDCl₃): δ = 12.08 (s, 1 H), 7.95–7.83 (m, 1 H), 7.50–7.44 (m, 1 H), 7.25–7.18 (m, 4 H), 7.14–7.10 (m, 2 H), 5.59 (s, 1 H), 4.31–4.18 (m, 2 H), 2.36 (s, 3 H), 1.27 (t, J = 7.2 Hz, 3 H). ¹³C NMR (100 MHz, CDCl₃): δ = 177.8, 163.5, 163.2, 152.6, 138.6, 133.1, 132.5, 127.8, 127.0, 124.1, 124.0, 116.8, 116.3, 100.9, 63.6, 48.3, 15.7, 13.9. HRMS (ESI): m/z [M + H]⁺ calcd for C₂₀H₁₉O₅S⁺: 371.0948; found: 371.0951.
• 16a Ciszewski LW, Rybicka-Jasinska K, Gryko D. Org. Biomol. Chem. 2019; 17: 432
• 16b Candeias NR, Paterna R, Gois PM. P. Chem. Rev. 2016; 116: 2937
• 17a Davies HM. L, Beckwith RE. J. Chem. Rev. 2003; 103: 2861
• 17b Zhang Z, Wang J. Tetrahedron 2008; 64: 6577
• 17c Davies HM. L, Denton JR. Chem. Soc. Rev. 2009; 38: 3061
• 17d Doyle MP, Duffy R, Ratnikov M, Zhou L. Chem. Rev. 2010; 110: 704
• 17e Ford A, Miel H, Ring A, Slattery CN, Maguire AR, McKervey MA. Chem. Rev. 2015; 115: 9981